Zimmer Biomet Holdings Return on Investment 2006-2019 | ZBH
Current and historical return on investment (ROI) values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
| Zimmer Biomet Holdings ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2019-03-31 | $0.08B | $19.85B | 0.38% |
| 2018-12-31 | $0.03B | $19.69B | 0.16% |
| 2018-09-30 | $0.78B | $20.82B | 3.71% |
| 2018-06-30 | $0.77B | $21.46B | 3.71% |
| 2018-03-31 | $0.76B | $21.49B | 3.71% |
| 2017-12-31 | $0.80B | $20.65B | 3.97% |
| 2017-09-30 | $1.02B | $19.65B | 5.08% |
| 2017-06-30 | $1.00B | $19.63B | 4.94% |
| 2017-03-31 | $0.92B | $20.47B | 4.53% |
| 2016-12-31 | $0.82B | $20.34B | 4.01% |
| 2016-09-30 | $0.86B | $20.75B | 4.13% |
| 2016-06-30 | $0.78B | $20.08B | 3.70% |
| 2016-03-31 | $0.44B | $20.78B | 2.07% |
| 2015-12-31 | $0.47B | $21.39B | 2.32% |
| 2015-09-30 | $0.48B | $21.68B | 2.83% |
| 2015-06-30 | $0.61B | $21.88B | 4.59% |
| 2015-03-31 | $1.01B | $15.64B | 10.14% |
| 2014-12-31 | $1.04B | $7.98B | 12.96% |
| 2014-09-30 | $1.16B | $7.97B | 14.55% |
| 2014-06-30 | $1.12B | $8.14B | 14.08% |
| 2014-03-31 | $1.07B | $7.92B | 13.68% |
| 2013-12-31 | $1.07B | $7.97B | 13.87% |
| 2013-09-30 | $0.92B | $7.83B | 12.12% |
| 2013-06-30 | $0.96B | $7.58B | 12.71% |
| 2013-03-31 | $1.05B | $7.42B | 14.00% |
| 2012-12-31 | $1.05B | $7.59B | 14.06% |
| 2012-09-30 | $1.05B | $7.57B | 14.29% |
| 2012-06-30 | $1.07B | $7.44B | 14.75% |
| 2012-03-31 | $1.02B | $7.23B | 14.29% |
| 2011-12-31 | $1.02B | $7.09B | 14.42% |
| 2011-09-30 | $0.95B | $7.15B | 13.40% |
| 2011-06-30 | $0.95B | $7.16B | 13.57% |
| 2011-03-31 | $0.92B | $7.01B | 13.26% |
| 2010-12-31 | $0.92B | $6.91B | 13.30% |
| 2010-09-30 | $1.03B | $6.96B | 15.06% |
| 2010-06-30 | $0.97B | $6.87B | 14.27% |
| 2010-03-31 | $1.03B | $6.84B | 15.52% |
| 2009-12-31 | $1.02B | $6.77B | 15.68% |
| 2009-09-30 | $1.02B | $6.58B | 16.10% |
| 2009-06-30 | $1.03B | $6.46B | 16.60% |
| 2009-03-31 | $1.04B | $6.22B | 17.22% |
| 2008-12-31 | $1.09B | $6.11B | 18.38% |
| 2008-09-30 | $1.20B | $5.95B | 20.76% |
| 2008-06-30 | $1.12B | $5.83B | 19.82% |
| 2008-03-31 | $1.13B | $5.82B | 20.50% |
| 2007-12-31 | $1.13B | $5.55B | 20.98% |
| 2007-09-30 | $1.11B | $5.36B | 21.25% |
| 2007-06-30 | $1.24B | $5.38B | 24.23% |
| 2007-03-31 | $1.20B | $5.22B | 23.90% |
| 2006-12-31 | $1.17B | $5.02B | 23.43% |
| 2006-09-30 | $1.11B | $4.91B | 22.57% |
| 2006-06-30 | $1.10B | $4.98B | 22.65% |
| 2006-03-31 | $1.09B | $5.01B | 23.01% |
| 2005-12-31 | $1.06B | $4.76B | 22.82% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.226B | $7.933B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $149.955B | 29.11 |
| Medtronic (MDT) | Ireland | $133.284B | 19.04 |
| Stryker (SYK) | United States | $75.636B | 26.99 |
| Boston Scientific (BSX) | United States | $57.976B | 27.79 |
| Baxter (BAX) | United States | $42.043B | 26.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.156B | 0.00 |
| ResMed (RMD) | United States | $17.217B | 32.90 |
| Canopy Growth (CGC) | Canada | $13.835B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.076B | 48.12 |
| Aurora Cannabis (ACB) | Canada | $7.403B | 73.00 |
| Insulet (PODD) | United States | $7.147B | 520.74 |
| Hill-Rom Holdings (HRC) | United States | $6.992B | 21.20 |
| Perrigo (PRGO) | Ireland | $6.052B | 10.23 |
| Haemonetics (HAE) | United States | $6.021B | 49.14 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.237B | 0.00 |
| ICU Medical (ICUI) | United States | $5.130B | 30.61 |
| Hutchison China MediTech (HCM) | China | $3.814B | 0.00 |
| Neogen (NEOG) | United States | $3.238B | 52.65 |
| Agios Pharmaceuticals (AGIO) | United States | $2.981B | 0.00 |
| NuVasive (NUVA) | United States | $2.962B | 24.19 |
| National Vision Holdings (EYE) | United States | $2.499B | 53.25 |
| Quidel (QDEL) | United States | $2.360B | 24.49 |
| Aphria (APHA) | $1.687B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.495B | 858.80 |
| Phibro Animal Health (PAHC) | United States | $1.220B | 18.28 |
| AtriCure (ATRC) | United States | $1.159B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.119B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $1.081B | 28.71 |
| OrganiGram Holdings (OGI) | Canada | $0.993B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.935B | 0.00 |
| PetIQ (PETQ) | United States | $0.899B | 21.84 |
| Quanterix (QTRX) | United States | $0.846B | 0.00 |
| MacroGenics (MGNX) | United States | $0.812B | 0.00 |
| Omeros (OMER) | United States | $0.794B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 21.61 |
| Cerus (CERS) | United States | $0.682B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.638B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 83.20 |
| OraSure Technologies (OSUR) | United States | $0.552B | 25.40 |
| LeMaitre Vascular (LMAT) | United States | $0.545B | 26.37 |
| Meridian Bioscience (VIVO) | United States | $0.489B | 14.95 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Vapotherm (VAPO) | United States | $0.364B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.355B | 0.00 |
| Zynex (ZYXI) | United States | $0.355B | 36.73 |
| BioLife Solutions (BLFS) | United States | $0.311B | 97.41 |
| Utah Medical Products (UTMD) | United States | $0.302B | 20.93 |
| Bovie Medical (APYX) | United States | $0.217B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.210B | 0.00 |
| Owens & Minor (OMI) | United States | $0.193B | 4.08 |
| Chimerix (CMRX) | United States | $0.173B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.172B | 0.00 |
| Fonar (FONR) | United States | $0.140B | 7.38 |
| Female Health (VERU) | United States | $0.134B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.111B | 0.00 |
| Neurotrope (NTRP) | United States | $0.100B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| Surface Oncology (SURF) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 19.21 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Senestech (SNES) | United States | $0.039B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.039B | 13.58 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.031B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.030B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.015B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.012B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.007B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 3.73 |
